| # | Drug | Count |
|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 2 |
| 1 | CYCLOPHOSPHAMIDE | 2 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 4 | DEXAMETHASONE | 2 |
| 5 | DEXAMETHASONE 1.5 MG | 2 |
| 6 | FLUDARABINE PHOSPHATE | 2 |
| 7 | LEVETIRACETAM | 2 |
| 8 | LEVETIRACETAM IN SODIUM CHLORIDE | 2 |
| 9 | LEVETIRACETAM INJECTION | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LISOCABTAGENE MARALEUCEL | 2 | 0.0023 |
| 1 | AXICABTAGENE CILOLEUCEL | 2 | 0.0002 |
| 2 | BLINATUMOMAB | 1 | 0.0001 |
| 3 | IRINOTECAN HYDROCHLORIDE | 1 | 0.0001 |
| 4 | FLUDARABINE PHOSPHATE | 2 | 0.0001 |
| 5 | DURVALUMAB | 1 | 0.0000 |
| 6 | LEVETIRACETAM ORAL | 2 | 0.0000 |
| 7 | LEVETIRACETAM INJECTION | 2 | 0.0000 |
| 8 | CYTARABINE | 1 | 0.0000 |
| 9 | LEVETIRACETAM | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 2 | 0.0002 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 2 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Corticosteroid [EPC] | 3 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |